Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$9.81 - $12.62 $38,259 - $49,218
3,900 Added 30.59%
16,650 $187,000
Q2 2023

Aug 09, 2023

SELL
$8.08 - $10.37 $74,602 - $95,746
-9,233 Reduced 42.0%
12,750 $128,000
Q1 2023

May 04, 2023

SELL
$8.79 - $14.58 $11,356 - $18,837
-1,292 Reduced 5.55%
21,983 $206,000
Q4 2022

Feb 09, 2023

SELL
$11.49 - $13.65 $80,625 - $95,782
-7,017 Reduced 23.16%
23,275 $284,000
Q4 2022

Feb 06, 2023

BUY
$11.49 - $13.65 $12,259 - $14,564
1,067 Added 3.65%
30,292 $370,000
Q3 2022

Nov 07, 2022

SELL
$12.41 - $32.42 $19,136 - $49,991
-1,542 Reduced 5.01%
29,225 $363,000
Q2 2022

Aug 08, 2022

BUY
$19.63 - $26.62 $2,453 - $3,327
125 Added 0.41%
30,767 $604,000
Q1 2022

May 13, 2022

SELL
$24.65 - $29.0 $5,546 - $6,525
-225 Reduced 0.73%
30,642 $799,000
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $7,628 - $9,374
275 Added 0.9%
30,867 $876,000
Q3 2021

Dec 08, 2021

BUY
$29.2 - $36.72 $893,286 - $1.12 Million
30,592 New
30,592 $977,000
Q3 2021

Nov 05, 2021

SELL
$29.2 - $36.72 $761,886 - $958,098
-26,092 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$28.76 - $35.98 $112,164 - $140,322
3,900 Added 17.57%
26,092 $905,000
Q1 2021

May 12, 2021

BUY
$27.85 - $34.49 $20,748 - $25,695
745 Added 3.47%
22,192 $656,000
Q4 2020

Feb 11, 2021

BUY
$27.53 - $33.79 $50,379 - $61,835
1,830 Added 9.33%
21,447 $658,000
Q3 2020

Nov 09, 2020

BUY
$21.1 - $29.13 $12,427 - $17,157
589 Added 3.1%
19,617 $548,000
Q2 2020

Aug 13, 2020

BUY
$18.94 - $24.93 $120,799 - $159,003
6,378 Added 50.42%
19,028 $403,000
Q1 2020

May 12, 2020

SELL
$16.68 - $32.25 $97,578 - $188,662
-5,850 Reduced 31.62%
12,650 $281,000
Q4 2019

Jan 28, 2020

BUY
$25.29 - $29.45 $163,120 - $189,952
6,450 Added 53.53%
18,500 $544,000
Q3 2019

Oct 22, 2019

BUY
$25.62 - $34.96 $308,721 - $421,268
12,050 New
12,050 $323,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.